Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 19, 2020
Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects
Samuel Israel, Ashish Kumar, Kiernan DeAngelis, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
November 25, 2003
Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma
Robert A Nathan, Paul Dorinsky, Jacqueline R Carranza Rosenzweig, et al.
Pharmacoeconomics
|
August 6, 2004
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma
Richard D O'Connor, Harold Nelson, Rohit Borker, et al.
Respiratory Research
|
October 8, 2021
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
Omar Usmani, Nicolas Roche, Ezanul Wahab, et al.
Respiratory Medicine
|
May 5, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study
Dave Singh, Klaus F Rabe, Fernando J Martinez, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 4, 2004
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists
John Murray, Richard Rosenthal, Laura Somerville, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
October 10, 2003
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment
Harold S Nelson, James D Wolfe, Gary Gross, et al.
Clinical Therapeutics
|
April 16, 2019
Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-blind, Parallel-group Study
Qian Chen, Chaoying Hu, Hui Yu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 22, 2004
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs
Richard D O'Connor, Richard Stanford, Courtney Crim, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
October 28, 2008
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down"
Steven M Koenig, Nancy Ostrom, David Pearlman, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 19, 2020
Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects
Samuel Israel, Ashish Kumar, Kiernan DeAngelis, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
November 25, 2003
Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma
Robert A Nathan, Paul Dorinsky, Jacqueline R Carranza Rosenzweig, et al.
Pharmacoeconomics
|
August 6, 2004
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma
Richard D O'Connor, Harold Nelson, Rohit Borker, et al.
Respiratory Research
|
October 8, 2021
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
Omar Usmani, Nicolas Roche, Ezanul Wahab, et al.
Respiratory Medicine
|
May 5, 2022
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study
Dave Singh, Klaus F Rabe, Fernando J Martinez, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 4, 2004
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists
John Murray, Richard Rosenthal, Laura Somerville, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
October 10, 2003
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment
Harold S Nelson, James D Wolfe, Gary Gross, et al.
Clinical Therapeutics
|
April 16, 2019
Pharmacokinetics and Tolerability of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate and Glycopyrronium/Formoterol Fumarate Dihydrate Metered Dose Inhalers in Healthy Chinese Adults: A Randomized, Double-blind, Parallel-group Study
Qian Chen, Chaoying Hu, Hui Yu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 22, 2004
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs
Richard D O'Connor, Richard Stanford, Courtney Crim, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
October 28, 2008
Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down"
Steven M Koenig, Nancy Ostrom, David Pearlman, et al.
Page
of 6